| The complex crosstalk between mitochondria and the nucleus: What goes in between? U Cagin, JA Enriquez The international journal of biochemistry & cell biology 63, 10-15, 2015 | 115 | 2015 |
| Photocatalytically active graphitic carbon nitride as an effective and safe 2D material for in vitro and in vivo photodynamic therapy H Taheri, MA Unal, M Sevim, C Gurcan, O Ekim, A Ceylan, Z Syrgiannis, ... Small 16 (10), 1904619, 2020 | 70 | 2020 |
| Mitochondrial retrograde signaling regulates neuronal function U Cagin, OF Duncan, AP Gatt, MS Dionne, ST Sweeney, JM Bateman Proceedings of the National Academy of Sciences 112 (44), E6000-E6009, 2015 | 63 | 2015 |
| Unkempt is negatively regulated by mTOR and uncouples neuronal differentiation from growth control A Avet-Rochex, N Carvajal, CP Christoforou, K Yeung, KT Maierbrugger, ... PLoS genetics 10 (9), e1004624, 2014 | 58 | 2014 |
| Rescue of advanced Pompe disease in mice with hepatic expression of secretable acid α-glucosidase U Cagin, F Puzzo, MJ Gomez, M Moya-Nilges, P Sellier, C Abad, ... Molecular Therapy 28 (9), 2056-2072, 2020 | 19 | 2020 |
| Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment P Laforêt, M Inoue, E Goillot, C Lefeuvre, U Cagin, N Streichenberger, ... Acta neuropathologica communications 7, 1-16, 2019 | 19 | 2019 |
| Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects P Colella, P Sellier, MJ Gomez, MG Biferi, G Tanniou, N Guerchet, ... EBioMedicine 61, 2020 | 16 | 2020 |
| Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates H Costa-Verdera, F Collaud, CR Riling, P Sellier, JML Nordin, ... Nature Communications 12 (1), 6393, 2021 | 14 | 2021 |
| Cellular reprogramming: A new way to understand aging mechanisms B Yener Ilce, U Cagin, A Yilmazer Wiley Interdisciplinary Reviews: Developmental Biology 7 (2), e308, 2018 | 12 | 2018 |
| Targeting mitochondrial defects to increase longevity in animal models of neurodegenerative diseases E Casajus Pelegay, F Puzzo, A Yilmazer, U Cagin Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders …, 2019 | 10 | 2019 |
| Reprogramming of human melanocytes and melanoma cells with yamanaka factors H Taheri, U Cagin, A Yilmazer Pre-Clinical Models: Techniques and Protocols, 249-261, 2019 | 4 | 2019 |
| Targeting age-related neurodegenerative diseases by AAV-Mediated gene therapy U Cagin Reviews on New Drug Targets in Age-Related Disorders: Part II, 213-223, 2021 | 3 | 2021 |
| O. 6Pre-clinical development of SPK-3006, an investigational liver-directed AAV gene therapy for the treatment of Pompe disease S Armour, J Nordin, HC Verdera, D Cohen, P Sellier, M Crosariol, ... Neuromuscular Disorders 29, S39, 2019 | 3 | 2019 |
| Safety and efficacy evaluation of investigational liver gene transfer for secretable GAA in the treatment of Pompe disease SM Armour, J Nordin, F Puzzo, U Cagin, M Crosariol, F Collaud, ... Mol Genet Metab 126, S24, 2019 | 2 | 2019 |
| Correction of Advanced Pompe Phenotype in Mice with AAV Liver Gene Transfer of Secretable GAA F Puzzo, U Cagin, M Moya-Nilges, L Van Wittenberghe, N Daniele, ... MOLECULAR THERAPY 26 (5), 312-312, 2018 | 2 | 2018 |
| Mitochondrial DNA-related disorders: emphasis on mechanisms and heterogeneity U Cagin, JA ENRIQUEZ Turkish Journal of Biology 39 (6), 840-855, 2015 | 2 | 2015 |
| Photodynamic Therapy: Photocatalytically Active Graphitic Carbon Nitride as an Effective and Safe 2D Material for In Vitro and In Vivo Photodynamic Therapy (Small 10/2020) H Taheri, MA Unal, M Sevim, C Gurcan, O Ekim, A Ceylan, Z Syrgiannis, ... Small 16 (10), 2070051, 2020 | 1 | 2020 |
| Latent TGF-beta-binding protein 4 modulates disease severity in the knock-out mouse model of Pompe disease P Colella, P Sellier, U Cagin, MG Biferi, N Guerchet, G Tanniou, ... Molecular Genetics and Metabolism 126 (2), S41, 2019 | 1 | 2019 |
| AAV-Mediated Liver Expression of Secretable GAA Shows Therapeutic Efficacy in Pompe Mice at Low Vector Doses F Puzzo, U Cagin, L Van Wittenberghe, N Daniele, N Guerchet, P Colella, ... MOLECULAR THERAPY 26 (5), 386-386, 2018 | 1 | 2018 |
| Cellular reprogramming: A new way to understand aging mechanisms. U Cagin, A Yilmazer Wiley Interdisciplinary reviews. Developmental Biology 7 (2), 2018 | 1 | 2018 |
